Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report

por Bowman, Christopher, Abramson, Vandana, Wellons, Melissa
Publicado 2017

Grade 3 Hepatotoxicity following Fulvestrant, Palbociclib, and Erdafitinib Therapy in a Patient with ER-Positive/PR-Negative/HER2-Negative Metastatic Breast Cancer: A Case Report

por Schlotman, Alyssa, Stater, Adam, Schuler, Kyle, Heideman, Judd, Abramson, Vandana
Publicado 2020

Using the HER2/CEP17 FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer

por Lander, Eric M, Rappazzo, Katherine C, Huang, Li-Ching, Hu, Jiun-Ruey, Chen, Heidi, Shyr, Yu, Abramson, Vandana G
Publicado 2022

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer

por Yan, Chi, Yang, Jinming, Saleh, Nabil, Chen, Sheau-Chiann, Ayers, Gregory D., Abramson, Vandana G., Mayer, Ingrid A., Richmond, Ann
Publicado 2021

An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results

por Li, Xia, Abramson, Richard G, Arlinghaus, Lori R, Chakravarthy, Anuradha Bapsi, Abramson, Vandana, Mayer, Ingrid, Farley, Jaime, Delbeke, Dominique, Yankeelov, Thomas E
Publicado 2012

Quantitative Comparison of Prone and Supine PERCIST Measurements in Breast Cancer

por Whisenant, Jennifer G., Williams, Jason M., Kang, Hakmook, Arlinghaus, Lori R., Abramson, Richard G., Abramson, Vandana G., Fakhoury, Kareem, Chakravarthy, A. Bapsi, Yankeelov, Thomas E.
Publicado 2020

A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention

por Ridner, Sheila H., Dietrich, Mary S., Boyages, John, Koelmeyer, Louise, Elder, Elisabeth, Hughes, T. Michael, French, James, Ngui, Nicholas, Hsu, Jeremy, Abramson, Vandana G., Moore, Andrew, Shah, Chirag
Publicado 2022

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients

por Morrison, Gladys, Lenkala, Divya, LaCroix, Bonnie, Ziliak, Dana, Abramson, Vandana, Morrow, Phuong Khanh, Forero, Andres, Van Poznak, Catherine, Rugo, Hope S, Nanda, Rita, O'Donnell, Peter H., Huang, R. Stephanie
Publicado 2016

A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis

por Ridner, Sheila H., Dietrich, Mary S., Cowher, Michael S., Taback, Bret, McLaughlin, Sarah, Ajkay, Nicolas, Boyages, John, Koelmeyer, Louise, DeSnyder, Sarah M., Wagner, Jamie, Abramson, Vandana, Moore, Andrew, Shah, Chirag
Publicado 2019

Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?

por Lenneman, Carrie G, Abdallah, Wissam M, Smith, Holly M, Abramson, Vandana, Mayer, Ingrid A, Silverstein, Cheri, Silverstein, Cheri, Means-Powell, Julie, Paranjape, Sachin Y, Lenihan, Daniel, Sawyer, Douglas B, Raj, Satish R
Publicado 2014

Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes

por Dietrich, Mary S., Gaitatzis, Katrina, Koelmeyer, Louise, Boyages, John, Abramson, Vandana G., McLaughlin, Sarah A., Ngui, Nicholas, Elder, Elisabeth, French, James, Hsu, Jeremy, Hughes, T. Michael, Stolldorf, Deonni P., Shah, Chirag, Ridner, Sheila H.
Publicado 2023

53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB)

por Lin, Nancy, Murthy, Rashmi, Anders, Carey, Borges, Virginia, Hurvitz, Sara, Loi, Sherene, Abramson, Vandana, Bedard, Philippe, Oliveira, Mafalda, Zelnack, Amelia, DiGiovanna, Michael, Bachelot, Thomas, Chien, A Jo, O’Regan, Ruth, Wardley, Andrew, Mueller, Volkmar, Carey, Lisa, McGoldrick, Suzanne, An, Xuebei, Winer, Eric
Publicado 2020

Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer

por Telli, Melinda L., Tolaney, Sara M., Shapiro, Geoffrey I., Middleton, Mark, Lord, Simon R., Arkenau, Hendrik Tobias, Tutt, Andrew, Abramson, Vandana, Dean, Emma, Haddad, Tufia C., Wesolowski, Robert, Ferrer-Playan, Jordi, Goddemeier, Thomas, Grombacher, Thomas, Dong, Jennifer, Fleuranceau-Morel, Patricia, Diaz-Padilla, Ivan, Plummer, Ruth
Publicado 2022

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer

por Wardley, Andrew, Cortes, Javier, Provencher, Louise, Miller, Kathy, Chien, A. Jo, Rugo, Hope S., Steinberg, Joyce, Sugg, Jennifer, Tudor, Iulia C., Huizing, Manon, Young, Robyn, Abramson, Vandana, Bose, Ron, Hart, Lowell, Chan, Stephen, Cameron, David, Wright, Gail S., Graas, Marie-Pascale, Neven, Patrick, Rocca, Andrea, Russo, Stefania, Krop, Ian E.
Publicado 2021

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases

por Anders, Carey, Deal, Allison M., Abramson, Vandana, Liu, Minetta C., Storniolo, Anna M., Carpenter, John T., Puhalla, Shannon, Nanda, Rita, Melhem-Bertrandt, Amal, Lin, Nancy U., Kelly Marcom, P., Van Poznak, Catherine, Stearns, Vered, Melisko, Michelle, Smith, J. Keith, Karginova, Olga, Parker, Joel, Berg, Jonathan, Winer, Eric P., Peterman, Amy, Prat, Aleix, Perou, Charles M., Wolff, Antonio C., Carey, Lisa A.
Publicado 2014

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases...

por Lin, Nancy U., Murthy, Rashmi K., Abramson, Vandana, Anders, Carey, Bachelot, Thomas, Bedard, Philippe L., Borges, Virginia, Cameron, David, Carey, Lisa A., Chien, A. Jo, Curigliano, Giuseppe, DiGiovanna, Michael P., Gelmon, Karen, Hortobagyi, Gabriel, Hurvitz, Sara A., Krop, Ian, Loi, Sherene, Loibl, Sibylle, Mueller, Volkmar, Oliveira, Mafalda, Paplomata, Elisavet, Pegram, Mark, Slamon, Dennis, Zelnak, Amelia, Ramos, Jorge, Feng, Wentao, Winer, Eric
Publicado 2022

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

por Lin, Nancy U., Borges, Virginia, Anders, Carey, Murthy, Rashmi K., Paplomata, Elisavet, Hamilton, Erika, Hurvitz, Sara, Loi, Sherene, Okines, Alicia, Abramson, Vandana, Bedard, Philippe L., Oliveira, Mafalda, Mueller, Volkmar, Zelnak, Amelia, DiGiovanna, Michael P., Bachelot, Thomas, Chien, A. Jo, O’Regan, Ruth, Wardley, Andrew, Conlin, Alison, Cameron, David, Carey, Lisa, Curigliano, Giuseppe, Gelmon, Karen, Loibl, Sibylle, Mayor, JoAl, McGoldrick, Suzanne, An, Xuebei, Winer, Eric P.
Publicado 2020

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

por Xing, Yan, Lin, Nancy U., Maurer, Matthew A., Chen, Huiqin, Mahvash, Armeen, Sahin, Aysegul, Akcakanat, Argun, Li, Yisheng, Abramson, Vandana, Litton, Jennifer, Chavez-MacGregor, Mariana, Valero, Vicente, Piha-Paul, Sarina A., Hong, David, Do, Kim-Anh, Tarco, Emily, Riall, Dianna, Eterovic, Agda Karina, Wulf, Gerburg M., Cantley, Lewis C., Mills, Gordon B., Doyle, L. Austin, Winer, Eric, Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda
Publicado 2019

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

por Parsons, Heather A., Blewett, Timothy, Chu, Xiangying, Sridhar, Sainetra, Santos, Katheryn, Xiong, Kan, Abramson, Vandana G., Patel, Ashka, Cheng, Ju, Brufsky, Adam, Rhoades, Justin, Force, Jeremy, Liu, Ruolin, Traina, Tiffany A., Carey, Lisa A., Rimawi, Mothaffar F., Miller, Kathy D., Stearns, Vered, Specht, Jennifer, Falkson, Carla, Burstein, Harold J., Wolff, Antonio C., Winer, Eric P., Tayob, Nabihah, Krop, Ian E., Makrigiorgos, G. Mike, Golub, Todd R., Mayer, Erica L., Adalsteinsson, Viktor A.
Publicado 2023

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes

por Lenz, Lauren, Neff, Chris, Solimeno, Cara, Cogan, Elizabeth S., Abramson, Vandana G., Boughey, Judy C., Falkson, Carla, Goetz, Matthew P., Ford, James M., Gradishar, William J., Jankowitz, Rachel C., Kaklamani, Virginia G., Marcom, P. Kelly, Richardson, Andrea L., Storniolo, Anna Maria, Tung, Nadine M., Vinayak, Shaveta, Hodgson, Darren R., Lai, Zhongwu, Dearden, Simon, Hennessy, Bryan T., Mayer, Erica L., Mills, Gordon B., Slavin, Thomas P., Gutin, Alexander, Connolly, Roisin M., Telli, Melinda L., Stearns, Vered, Lanchbury, Jerry S., Timms, Kirsten M.
Publicado 2023